Table 2.

Patients with inflammatory bowel disease and potential high risk of severe COVID-19, based on SECURE-IBD database information on 1 April 2020 [43]

IBD patients with potential risk of severe COVID-19
Patients with comorbidities (hypertension, diabetes mellitus, cardiovascular and chronic kidney disease)
Patients with >60 years old
Patients with severe IBD activity
Patients with corticosteroid therapy (>20 mg/day of prednisone)
Patients with combination therapy (anti-TNF plus thiopurine or methotrexate)
Patients with JAK inhibitor therapy

Anti-TNF, anti tumor necrosis factor; COVID-19, coronavirus disease 2019; IBD, inflammatory bowel disease; JAK, janus kinase.